+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

France Neuromodulation Devices Market Outlook to 2025

  • PDF Icon

    Report

  • 60 Pages
  • November 2018
  • Region: France
  • GlobalData
  • ID: 4668078
Description Jump to:
France Neuromodulation Devices Market Outlook to 2025

Summary

the new report, France Neuromodulation Devices Market Outlook to 2025, provides key market data on the France Neuromodulation Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS).

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Neuromodulation Devices market segments - Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS)..

  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.

  • 2017 company share and distribution share data for Neuromodulation Devices market.

  • Global corporate-level profiles of key companies operating within the France Neuromodulation Devices market.

  • Key players covered include Abbott Healthcare Pvt Ltd, Boston Scientific Corp, Medtronic plc and others.


Reasons to Buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.

  • Develop market-entry and market expansion strategies.

  • Design competition strategies by identifying who-stands-where in the market.

  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Neuromodulation Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neuromodulation Devices Market, France
3.1 Neuromodulation Devices Market, France, Revenue ($m), 2015-2025
3.2 Neuromodulation Devices Market, France, Volume (Units), 2015-2025
3.3 Neuromodulation Devices Market, France, Average Price ($), 2015-2025
3.4 Neuromodulation Devices Market, France, Distribution Share by Revenue ($m), 2017
3.5 Neuromodulation Devices Market, France, Company Share by Revenue ($m), 2017
4 Overview of Key Companies in France, Neuromodulation Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Boston Scientific Corp
4.2.1 Company Overview
4.3 Nevro Corp
4.3.1 Company Overview
4.4 LivaNova PLC
4.4.1 Company Overview
4.5 Abbott Laboratories
4.5.1 Company Overview
5 Neuromodulation Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Debt Offerings
6.1.1 Sanofi Prices First Tranche of Public Offering of Notes Due 2020 for USD1.2 Billion
6.1.2 Sanofi Prices Second Tranche of Public Offering of Notes Due 2020 for USD0.6 Billion
6.1.3 Sanofi Prices Third Tranche of Public Offering of 0.5% Notes Due 2023 for USD2.2 Billion
6.1.4 Sanofi Prices Fourth Tranche of Public Offering of 1% Notes Due 2026 for USD1.9 Billion
6.1.5 Sanofi Prices Fifth Tranche of Public Offering of 1.375% Notes Due 2030 for USD2.47 Billion
6.1.6 Sanofi Prices Sixth Tranche of Public Offering of 1.875% Notes Due 2038 for USD1.54 Billion
6.1.7 Visiomed Group Raises USD8.1 Million in First Tranche of Private Placement of Notes
7 Recent Developments
7.1 Corporate Communications
7.1.1 Jun 19, 2018: Sanofi appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President, Chief Financial Officer
7.1.2 May 08, 2018: Sanofi Announces Appointment of Mr. Charles Billard as Chief Financial Officer and Key Managerial Personnel
7.1.3 Apr 24, 2018: Sanofi Head of Global R&D Elias Zerhouni to retire; Company names John Reed to take over on July
7.1.4 Mar 06, 2018: Sanofi’s Board of Directors Proposes Appointment of Emmanuel Babeau as New Independent Director
7.1.5 Jan 19, 2018: Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee
7.2 Financial Announcements
7.2.1 Mar 28, 2018: Sanofi: Pre - quarterly R esults C ommunication
7.2.2 Nov 02, 2017: Sanofi: Q3 2017 Business EPS up 1.1% at CER FY 2017 Guidance Confirmed
7.3 Other Significant Developments
7.3.1 May 28, 2018: Beactica Signs Three-Year Extension Agreement With Sanofi
7.3.2 Apr 27, 2018: Sanofi: First-quarter 2018 Business EPS up 1.4% at CER
7.3.3 Feb 07, 2018: Sanofi Delivers 2017 Business EPS in line with Guidance
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 Consulting
8.3 Contact Us
8.4 Disclaimer
List of Tables
Table 1: Neuromodulation Devices Market, France, Revenue ($m), USD Constant, 2015-2020
Table 2: Neuromodulation Devices Market, France, Revenue ($m), USD Constant, 2021-2025
Table 3: Neuromodulation Devices Market, France, Volume (Units), 2015-2020
Table 4: Neuromodulation Devices Market, France, Volume (Units), 2021-2025
Table 5: Neuromodulation Devices Market, France, Average Price ($), 2015-2020
Table 6: Neuromodulation Devices Market, France, Average Price ($), 2021-2025
Table 7: Neuromodulation Devices Market, France, Distribution Share by Revenue ($m), USD Constant, 2017
Table 8: Neuromodulation Devices Market, France, Company Share by Revenue ($m), USD Constant, 2017
Table 9: Neuromodulation Devices Market Pipeline Products
Table 10: Sanofi Prices First Tranche of Public Offering of Notes Due 2020 for USD1.2 Billion
Table 11: Sanofi Prices Second Tranche of Public Offering of Notes Due 2020 for USD0.6 Billion
Table 12: Sanofi Prices Third Tranche of Public Offering of 0.5% Notes Due 2023 for USD2.2 Billion
Table 13: Sanofi Prices Fourth Tranche of Public Offering of 1% Notes Due 2026 for USD1.9 Billion
Table 14: Sanofi Prices Fifth Tranche of Public Offering of 1.375% Notes Due 2030 for USD2.47 Billion
Table 15: Sanofi Prices Sixth Tranche of Public Offering of 1.875% Notes Due 2038 for USD1.54 Billion
Table 16: Visiomed Group Raises USD8.1 Million in First Tranche of Private Placement of Notes
Table 17: Total Number of Primary Research Participants, Neurology Devices Market, by Country
List of Figures
Figure 1: Neuromodulation Devices Market, France, Revenue ($m), USD Constant, 2015-2025
Figure 2: Neuromodulation Devices Market, France, Volume (Units), 2015-2025
Figure 3: Neuromodulation Devices Market, France, Company Share (%) 2017

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic Plc

  • Boston Scientific Corp

  • Nevro Corp

  • LivaNova PLC

  • Abbott Laboratories

Related Topics

Related Reports

Global Neuromodulation Devices Market by Product (Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators), Application (Neurological Disorders, Pain Management, Respiratory Disorders), End User - Forecast 2024-2030 - Product Image

Global Neuromodulation Devices Market by Product (Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators), Application (Neurological Disorders, Pain Management, Respiratory Disorders), End User - Forecast 2024-2030

  • Report
  • 186 Pages
  • Global
From
Internal Neuromodulation Devices Global Market Report 2024 - Product Image

Internal Neuromodulation Devices Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Neuromodulation Devices Market Report 2024-2034 - Product Image

Neuromodulation Devices Market Report 2024-2034

  • Report
  • 251 Pages
  • Global
From
France Neuromodulation Procedures Count by Segments and Forecast to 2030 - Product Image

France Neuromodulation Procedures Count by Segments and Forecast to 2030

  • Report
  • 17 Pages
  • France
From
EU5 Neuromodulation Procedures Count by Segments and Forecast to 2030 - Product Image

EU5 Neuromodulation Procedures Count by Segments and Forecast to 2030

  • Report
  • 39 Pages
  • Europe
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.